Toxic megacolon (TM) is a rare complication of severe ulcerative colitis (UC) and colonic Crohn's disease (CD), defined as a clinical syndrome accompanied by radiographic evidence of colonic dilatation that in many cases must be treated aggressively with surgical intervention (1). We report two cases of steroid and antibiotic-refractory fulminant Crohn's colitis, complicated by toxic megacolon, who were successfully treated with infliximab (IFX), thus avoiding surgical intervention. Although there are no well defined recommendation about the correct timing of colectomy in CD-associated TM, and despite the fact that it may be imprudent to advocate delaying surgery in favour of anti-tumor necrosis (anti-TNF) factor therapy in these cases, we think that a medical "rescue therapy" can be considered in a subset of patients with stable clinical condition during corticosteroid treatment.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Ameboma, a rare cause of intestinal obstruction in bariatric surgery patients: a case report.
J Surg Case Rep
December 2024
Bariatric Surgery, Obesity Goodbye Center, Tijuana 22000, Mexico.
Article Synopsis
- - Ameboma is a rare complication from invasive amebiasis caused by a specific intestinal protozoan, leading to tumor-like inflammatory masses in the lower right abdomen.
- - Symptoms can vary but often include intestinal obstruction and gastrointestinal bleeding, and while imaging techniques like CT and ultrasound can reveal colonic masses, biopsy remains the most reliable way to diagnose ameboma.
- - Treatment generally involves targeting the protozoan causing the infection, with surgery being necessary for severe cases like intestinal obstruction or other serious complications.
Loop Ileostomy With Colonic Lavage: Case Report of an Alternative to Total Colectomy in the Setting of Fulminant Clostridium difficile Colitis.
Cureus
November 2024
General Surgery, Broward Health and South Florida Surgical Specialists, Fort Lauderdale, USA.
Fulminant colitis is a severe and potentially life-threatening form of associated bacterial disease leading to inflammation and damage to the colon. Complications such as toxic megacolon, sepsis, and multi-organ failure commonly occur in individuals with compromised immune systems and recent antibiotic use. Management of colitis involves optimization of fluid and electrolyte balance, and elimination of bacteria commonly by administering vancomycin or fidaxomicin.
View Article and Find Full Text PDFIn recent years, there has been a significant rise in both the frequency and severity of colitis. This infection presents a broad clinical spectrum, ranging from asymptomatic colonization to severe fulminant colitis, which often requires urgent surgical intervention. The failure of medical treatments and the development of toxic megacolon typically necessitate surgery, though it is associated with high mortality rates.
View Article and Find Full Text PDFN4-acetyl-sulfamethoxazole stone in a patient on chronic trimethoprim/sulfamethoxazole therapy: a case report and literature review.
Am J Clin Exp Urol
October 2024
Department of Urology, University of Florida Gainesville, FL 32610, USA.
Article Synopsis
- - The case report highlights a rare instance of urolithiasis (kidney stones) related to the metabolite N4-acetyl-sulfamethoxazole, following prolonged treatment with trimethoprim/sulfamethoxazole (TMP-SMX).
- - The patient had undergone a total colectomy and had a history of benign prostatic hypertrophy and chronic urinary retention, which contributed to metabolic conditions that increased the risk of stone formation.
- - The stones were analyzed using light microscopy and scanning electron microscopy (SEM), revealing rectangular-shaped crystals, marking the first time such crystals have been characterized using SEM.
Superiority of frailty over age in predicting outcomes among clostridium difficile patients: Evidence from national data.
Clin Res Hepatol Gastroenterol
November 2024
Department of Gastroenterology, Cleveland Clinic Florida, FL, USA.
Article Synopsis
- Clostridium difficile infection (CDI) is an increasing healthcare problem linked to higher risks and poor outcomes, particularly in frail patients, whose impact on CDI has been insufficiently studied.
- An analysis of over 144,000 adult CDI patients from the National Readmission Database revealed that 67.88% were frail, with frailty significantly increasing the risk of mortality, complications, and intensive care admission.
- The findings suggest that frailty should be recognized as a key factor influencing CDI outcomes, which can help clinicians in better risk stratification and developing targeted treatment strategies for affected individuals.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!